Primary Care and Diabetes Group of Kendall

Endocrinology in Miami, Florida

Practice Details

Address
8200 SW 117th Ave
Miami, FL 33183
Geocoded location: 25.6918, -80.3820
Taxonomy
Endocrinology, Diabetes & Metabolism
NPPES Enumeration
Listed with NPPES since 2009
Registered Contact
CRISTIAN BRETON, PRESIDENT
NPPES Record Updated
March 2009

About This Practice

This practice is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

This practice address has 8 individual clinicians enumerated with NPPES under the same location.

Locally, this is 1 of 103 Endocrinology, Diabetes & Metabolism practices in Miami carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Primary Care and Diabetes Group of Kendall's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 305-670-4424.

GLP-1 access in Miami, Florida

Adult obesity rate
30.1%
#33 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Florida telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Florida Medicaid, obesity indication

About 30.1% of Florida adults have obesity (BMI 30+), ranking the state #33 of 50 (CDC BRFSS). Our directory currently lists 197 GLP-1-relevant clinics in Miami. If a cash-pay route makes more sense, compounded semaglutide through Florida telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Florida options on the best Florida GLP-1 providers page, browse every Miami listing in the Miami clinic directory, or read the Florida Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Miami

Other Miami listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Florida addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Florida telehealth partners:

Featured Partners · Miami

Featured GLP-1 providers serving Miami

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Miami options on the Miami clinic directory, our Miami GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Miami obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Primary Care and Diabetes Group of Kendall's specialty taxonomy but not the specific medications it prescribes or its current service menu. Primary Care and Diabetes Group of Kendall is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 305-670-4424 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Primary Care and Diabetes Group of Kendall's primary specialty on file is Endocrinology.
Primary Care and Diabetes Group of Kendall is located at 8200 SW 117th Ave, Miami, FL 33183. The phone number listed in the registry is 305-670-4424. Its full record is public in the CMS National Provider registry under NPI 1316188089.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Primary Care and Diabetes Group of Kendall is currently accepting new patients. Call the practice at 305-670-4424 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.